Our tools can support Alzheimer researchers with their compounds and solutions — we have reached out to the Cell Reports Medicine team behind the 2025 P7C3-A20 / NAD+ reversal study (Pieper lab, Case Western Reserve / Harrington Discovery Institute) to offer that support, and welcome similar conversations with other groups. A European computational-biology team with 16 certified AAIC 2026 posters and 29 NeurIPS 2026 workshop papers, with further Alzheimer-specific papers at ICLR 2026 workshops covering genomics, drug-discovery, and biomedical-reasoning (Gen², MLGenX, World Models for AD treatment) — 54 accepted workshop papers across major venues total. To foundations and associations: we can work with the researchers you fund to design and fund wet-lab tests of promising hypotheses. To wet labs and CROs: if your team can run the experiment, we want to hear from you.
We are a self-funded computational-biology team accelerating Alzheimer's research. Foundations and associations are our most powerful allies — here is how we can build something meaningful together.
Your network is our most valuable resource. By amplifying our work, you directly accelerate Alzheimer's drug discovery.
You're not a research lab. You're a fundraising organization competing for donor dollars. Here's what a partnership with Reversal does for your foundation — not for researchers, for your organization.
We are flexible on structure. What matters is alignment on mission and impact.
enrique.zueco@alzheimersreversal.org · We respond within 48 hours
We are looking for wet labs and CROs that can run experimental tests of computational Alzheimer's hypotheses.
The Foundation funds outside wet-lab tests of its computational hypotheses. If your lab can run the experiment, we fund the test and publish the results.
Joint publications on validated results. The Foundation contributes computational hypotheses; you contribute experimental execution and domain expertise.
Scientists and domain experts are invited to review the Foundation's published hypotheses, flag weaknesses, and suggest experiments.
The Foundation publishes hypotheses with structural data, pathway analyses, and predicted mechanisms in standard formats, so any lab can evaluate and build on them independently.
The Foundation does not sell services or software. The results of every test it funds are published, so any lab or company can build on them.
Tell us about your lab and your interest in the Foundation's work. We will set up a call to discuss how we can work together.